PEPTIDE RECEPTOR RADIONUCLIDE THERAPY FOR METASTATIC MEDULLARY THYROID CARCINOMA: A WESTERN AUSTRALIAN EXPERIENCE

被引：0
|
作者：
Pugazhenthi, Kamali [1 ]
机构：
[1] Fiona Stanley Hosp, Murdoch, WA, Australia
来源：
INTERNAL MEDICINE JOURNAL | 2023年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：43 / 43
页数：1
相关论文
共 50 条
  • [31] An Australian multi-centre experience of the use of peptide receptor radionuclide therapy for bronchial carcinoid tumours
    Lim, L. E.
    Chan, D. L.
    Thomas, D.
    Wyld, D. K.
    Cehic, G.
    Macdonald, W.
    Du, Y. T.
    Tincknell, G.
    Kuchel, A.
    Pavlakis, N.
    Bailey, D.
    Davis, A.
    Segelov, E.
    ANNALS OF ONCOLOGY, 2019, 30 : 572 - 572
  • [32] Hereditary medullary thyroid carcinoma syndromes: experience from western India
    Chakra Diwaker
    Vijaya Sarathi
    Sanjeet Kumar Jaiswal
    Ravikumar Shah
    Anuja Deshmukh
    Anand Ebin Thomas
    Gagan Prakash
    Gaurav Malhotra
    Virendra Patil
    Anurag Lila
    Nalini Shah
    Tushar Bandgar
    Familial Cancer, 2021, 20 : 241 - 251
  • [33] Medullary thyroid carcinoma metastatic to skin
    Nashed, Catherine
    Sakpal, Sujit Vijay
    Cherneykin, Sergey
    Chamberlain, Ronald Scott
    JOURNAL OF CUTANEOUS PATHOLOGY, 2010, 37 (12) : 1237 - 1240
  • [34] MEDULLARY CARCINOMA OF THE THYROID METASTATIC TO BREAST
    KIELY, N
    WILLIAMS, N
    WILSON, G
    WILLIAMS, RJ
    POSTGRADUATE MEDICAL JOURNAL, 1995, 71 (842) : 744 - 745
  • [35] Peptide receptor radionuclide therapy for metastatic bronchopulmonary carcinoid tumours: a single ENETS Centre of Excellence experience
    Evans, J.
    Yang, W. M.
    Newsom-Davis, T.
    Sharma, R.
    LUNG CANCER, 2019, 127 : S59 - S59
  • [36] A phase II trial of imatinib therapy for metastatic medullary thyroid carcinoma
    de Groot, J. W. B.
    Zonnenberg, B. A.
    van Ufford-Mannesse, P. Quarles
    de Vries, M. M.
    Links, T. P.
    Lips, C. J. M.
    Voest, E. E.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (09): : 3466 - 3469
  • [37] Complete Remission of Metastatic Neuroendocrine Paragastric Carcinoma After "Neoadjuvant" Peptide Receptor Radionuclide Therapy and Surgery
    Schmidt, Matthias C.
    Uhrhan, Klara
    Fischer, Thomas
    Schmitz, Stephan
    Markiefka, Birgid
    Drzezga, Alexander
    Stippel, Dirk
    CLINICAL NUCLEAR MEDICINE, 2015, 40 (08) : 667 - 669
  • [38] Peptide Receptor Radionuclide Therapy of Differentiated Thyroid Cancer: Efficacy and Toxicity
    Czepczynski, Rafal
    Matysiak-Grzes, Magdalena
    Gryczynska, Maria
    Baczyk, Maciej
    Wyszomirska, Anna
    Stajgis, Marek
    Ruchala, Marek
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2015, 63 (02) : 147 - 154
  • [39] Peptide Receptor Radionuclide Therapy of Differentiated Thyroid Cancer: Efficacy and Toxicity
    Rafał Czepczyński
    Magdalena Matysiak-Grześ
    Maria Gryczyńska
    Maciej Bączyk
    Anna Wyszomirska
    Marek Stajgis
    Marek Ruchała
    Archivum Immunologiae et Therapiae Experimentalis, 2015, 63 : 147 - 154
  • [40] Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma
    Kong, Grace
    Grozinsky-Glasberg, Simona
    Hofman, Michael S.
    Callahan, Jason
    Meirovitz, Amichay
    Maimon, Ofra
    Pattison, David A.
    Gross, David J.
    Hicks, Rodney J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 102 (09): : 3278 - 3287
12345